Bridging innovation and care
across Australia and New Zealand
We specialise in bringing clinically meaningful medical technologies to the ANZ market, combining commercial expertise, regulatory support, clinical engagement and national distribution to help innovative products reach the healthcare professionals and patients who can benefit from them most.
Our approach is focused and collaborative. By working with a carefully selected portfolio of technologies, we give every brand the attention, expertise and commitment required to build a meaningful and sustainable presence in the market.
Our leadership
Lucy Pilcher
Founder & Managing Director
As Founder and Managing Director of Lightly Medical, Lucy leads the business with a strong focus on quality, innovation and building lasting relationships with healthcare professionals and industry partners.
Having transitioned into the medical device sector through Marlin Medical, Lucy brings hands-on industry experience together with a proactive and highly focused approach to supporting innovative healthcare technologies in the Australian market.
David Pilcher
Director
David brings more than 20 years of sales and marketing experience within the Australian healthcare sector. His extensive medical device experience spans urology, gynaecology, colorectal surgery, capital equipment, theatre supplies, surgical products and patient positioning.
Having previously managed healthcare company Marlin Medical, David brings extensive market knowledge and commercial insight to the development and growth of Lightly Medical’s portfolio.
Why Lightly Medical?
ANZ market expertise
We believe in depth over breadth. Our carefully selected portfolio allows us to provide each technology with dedicated commercial, clinical and strategic attention.
Focused representation
We believe in depth over breadth. Our carefully selected portfolio allows us to provide each technology with dedicated commercial, clinical and strategic attention.
Clinical engagement
We work closely with healthcare professionals to support education, product implementation and the successful adoption of new technologies into clinical practice.
End-to-end support
From regulatory compliance and market-entry strategy through to launch, distribution, training and after-sales support, we provide a joined-up approach to commercialisation.
Long-term partnerships
We work as an extension of our manufacturing partners, building relationships based on trust, responsiveness and shared long-term objectives.
National reach. Local expertise.
Australia and New Zealand present unique distribution challenges, with healthcare providers spread across major metropolitan centres and extensive regional areas. Lightly Medical’s hybrid distribution model combines direct sales and clinical representation with a structured network of experienced local distributors.
This approach enables us to provide broad market coverage while maintaining consistent brand representation, responsive local support and meaningful engagement with healthcare professionals.
Local distribution network
Experienced partners extend reach and provide responsive support across metropolitan and regional markets.
Consistent implementation
Coordinated product education, training and commercial support help maintain a consistent experience as technologies are introduced and scaled across the ANZ market.
Direct representation
Focused engagement with key hospitals, clinicians and healthcare decision-makers.
Navigating the ANZ regulatory landscape
Successful market entry requires a clear understanding of the regulatory requirements governing medical technologies in Australia and New Zealand.
Lightly Medical supports manufacturing partners through the regulatory and market-entry process, including TGA compliance and Australian Register of Therapeutic Goods (ARTG) requirements, helping establish a compliant and efficient pathway from international innovation to the Australian healthcare market.
Our regulatory understanding is integrated with commercial planning, ensuring market access, launch preparation, clinical education and distribution form part of a coordinated market-entry strategy.
More than distribution
We don’t believe successful medical technology distribution is simply about moving products. We work closely with our manufacturing partners to understand their technology, clinical value and commercial objectives before developing an approach tailored to the ANZ healthcare market.
By maintaining a carefully curated portfolio, we can provide every partner with the focus their technology deserves — supporting regulatory requirements, market entry, clinical education, product launch, distribution and ongoing commercial development.
Our ambition is to become an extension of our partners’ teams, representing their brands with the same commitment, expertise and attention they would expect from their own organisation.
Interested in bringing your technology to Australia and New Zealand?
Our approach
Clinically meaningful innovation
We seek technologies that address real clinical challenges and have the potential to make a meaningful difference to healthcare professionals, patients and health systems.
Depth over breadth
We deliberately maintain a focused portfolio, allowing us to understand each technology in depth and give our partners the dedicated representation they deserve.
Partnership
Strong relationships sit at the heart of our approach. We work collaboratively with manufacturers, clinicians, healthcare organisations and distribution partners to achieve shared goals.
Practical implementation
Innovation only delivers value when it can be successfully introduced into everyday care. We focus on education, implementation and responsive support alongside commercial delivery.
Reliability
Our partners and customers need a team they can depend on. We approach every relationship with professionalism, responsiveness and a long-term commitment to delivering results.
Clinical Solutions.
Selected with purpose.
Orthopaedics
Post-operative swelling can delay mobility, extend recovery and affect the patient experience. Our orthopaedic solutions are selected to support circulation, manage oedema and help patients move forward with confidence.
geko® T3 (Wound Therapy Device)
A wearable neuromuscular electrostimulation device designed to increase lower-limb blood flow and support the prevention and management of post-operative oedema.
Wound Care
Hard-to-heal wounds place a significant burden on patients and clinical teams. Our wound-care solutions are selected to complement established care, improve circulation and support better healing outcomes.
geko® W3 (Wound Therapy Device)
The geko® device, powered by OnPulse™ neuromuscular electrostimulation technology, is clinically proven to increase blood flow for the promotion of wound healing and the reduction of oedema.
Clinical Solutions.
Selected with purpose.
Orthopaedics
Post-operative swelling can delay mobility, extend recovery and affect the patient experience. Our orthopaedic solutions are selected to support circulation, manage oedema and help patients move forward with confidence.
geko® T3 (Wound Therapy Device)
A wearable neuromuscular electrostimulation device designed to increase lower-limb blood flow and support the prevention and management of post-operative oedema.
Wound Care
Hard-to-heal wounds place a significant burden on patients and clinical teams. Our wound-care solutions are selected to complement established care, improve circulation and support better healing outcomes.
geko® W3 (Wound Therapy Device)
A wearable neuromuscular electrostimulation device designed to increase lower-limb blood flow and support the prevention and management of post-operative oedema.
ANZ. Unlocked.
Focused local expertise to help global MedTech brands enter, launch and grow.
